Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanically Engineered Exosomes for Thin Endometrium
NCT06896747Phase 2Recruiting
- Sponsor
- Tangdu Hospital
- Start
- Feb 2025
- Primary completion
- Jun 2025
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of Mechanically Engineered Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in thin endometrium, sponsored by Tangdu Hospital. Started Feb 2025; status: recruiting.
02
Drugs
Mechanically Engineered Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes
03
Conditions
thin endometrium
Beyond the preview
Go deeper on NCT06896747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06896747.